Breaking News Instant updates and real-time market news.

VRT

Vertiv Holdings

$21.17 /

-0.33 (-1.53%)

07:48
04/08/21
04/08
07:48
04/08/21
07:48

Vertiv Holdings initiated with an Overweight at JPMorgan

JPMorgan analyst Stephen Tusa initiated coverage of Vertiv Holdings with an Overweight rating and $25 price target. The analyst sees above-average organic growth and free cash flow improvement potential at an attractive valuation. Tusa views data centers as an above-average growth market within electrical equipment and says Vertiv is a leading global supplier to these facilities.

  • 28

    Apr

  • 13

    Aug

  • 13

    Nov

  • 01

    Mar

OTHER BREAKING NEWS FROM THE FLY

Hot Stocks
Atlantia agrees to acquire Yunex Traffic from Siemens » 18:03
01/17/22
01/17
18:03
01/17/22
18:03
ATASY

Atlantia

$9.84 /

+0.035 (+0.36%)

, SIEGY

Siemens

$83.76 /

-2.315 (-2.69%)

Atlantia (ATASY)…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SIEGY Siemens
$83.76 /

-2.315 (-2.69%)

ATASY Atlantia
$9.84 /

+0.035 (+0.36%)

10/26/21 UBS
Atlantia price target raised to EUR 18.80 from EUR 18.20 at UBS
08/11/21 Societe Generale
Atlantia upgraded to Buy from Hold at Societe Generale
05/14/21 Oddo BHF
Atlantia upgraded to Neutral from Underperform at Oddo BHF
SIEGY Siemens
$83.76 /

-2.315 (-2.69%)

01/14/22 Barclays
Siemens price target raised to EUR 141 from EUR 130 at Barclays
01/12/22 Deutsche Bank
Siemens price target raised to EUR 185 from EUR 180 at Deutsche Bank
12/07/21 Bernstein
Siemens initiated with an Underperform at Bernstein
11/26/21 Deutsche Bank
Siemens price target raised to EUR 180 from EUR 178 at Deutsche Bank
ATASY Atlantia
$9.84 /

+0.035 (+0.36%)

SIEGY Siemens
$83.76 /

-2.315 (-2.69%)

SIEGY Siemens
$83.76 /

-2.315 (-2.69%)

Conference/Events
Jefferies software/Internet analyst to hold analyst/industry conference call » 17:32
01/17/22
01/17
17:32
01/17/22
17:32
GOOG

Alphabet

$2,793.76 /

+12.71 (+0.46%)

, SONO

Sonos

$27.87 /

-1.62 (-5.49%)

Internet & Software…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GOOG Alphabet
$2,793.76 /

+12.71 (+0.46%)

SONO Sonos
$27.87 /

-1.62 (-5.49%)

GOOG Alphabet
$2,793.76 /

+12.71 (+0.46%)

01/13/22 Cowen
Alphabet price target raised to $3,500 from $3,360 at Cowen
01/11/22 JPMorgan
Amazon 'strong favorite' to be best performing FANG stock, JPMorgan says
01/11/22 Morgan Stanley
Amazon price target raised to $4,200 from $4,000 at Morgan Stanley
01/07/22 Morgan Stanley
Sonos' ITC win improves odds of potentially monetizing IP, says Morgan Stanley
SONO Sonos
$27.87 /

-1.62 (-5.49%)

01/07/22 Morgan Stanley
Sonos' ITC win improves odds of potentially monetizing IP, says Morgan Stanley
11/18/21 Morgan Stanley
Sonos price target raised to $53 from $51 at Morgan Stanley
09/14/21 Jefferies
Sonos price hikes support view FY22 consensus too low, says Jefferies
08/16/21
Fly Intel: Top five analyst upgrades
GOOG Alphabet
$2,793.76 /

+12.71 (+0.46%)

SONO Sonos
$27.87 /

-1.62 (-5.49%)

GOOG Alphabet
$2,793.76 /

+12.71 (+0.46%)

SONO Sonos
$27.87 /

-1.62 (-5.49%)

GOOG Alphabet
$2,793.76 /

+12.71 (+0.46%)

SONO Sonos
$27.87 /

-1.62 (-5.49%)

SONO Sonos
$27.87 /

-1.62 (-5.49%)

Conference/Events
Jefferies software/Internet analyst to hold analyst/industry conference call » 17:29
01/17/22
01/17
17:29
01/17/22
17:29
TEAM

Atlassian

$297.39 /

-0.99 (-0.33%)

Software & Internet…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TEAM Atlassian
$297.39 /

-0.99 (-0.33%)

TEAM Atlassian
$297.39 /

-0.99 (-0.33%)

01/06/22 Jefferies
Atlassian price target lowered to $355 from $460 at Jefferies
12/22/21
Fly Intel: Top five analyst initiations
12/22/21 KeyBanc
Atlassian resumed with an Overweight at KeyBanc
12/16/21 Goldman Sachs
Atlassian initiated with a Neutral at Goldman Sachs
TEAM Atlassian
$297.39 /

-0.99 (-0.33%)

TEAM Atlassian
$297.39 /

-0.99 (-0.33%)

TEAM Atlassian
$297.39 /

-0.99 (-0.33%)

Conference/Events
JPMorgan utilities/midstream analyst holds analyst/industry conference call » 17:24
01/17/22
01/17
17:24
01/17/22
17:24
APA

APA Corp.

$33.29 /

+1.2 (+3.74%)

, ALTM

Altus Midstream

$64.95 /

+1.385 (+2.18%)

Utilities & Midstream…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
APA APA Corp.
$33.29 /

+1.2 (+3.74%)

ALTM Altus Midstream
$64.95 /

+1.385 (+2.18%)

APA APA Corp.
$33.29 /

+1.2 (+3.74%)

01/14/22 Truist
APA Corp. price target raised to $53 from $45 at Truist
01/13/22 Scotiabank
APA Corp. price target raised to $38 from $36 at Scotiabank
01/06/22 Barclays
APA Corp. price target raised to $30 from $26 at Barclays
01/04/22 Stifel
APA Corp. price target raised to $37 from $33 at Stifel
ALTM Altus Midstream
$64.95 /

+1.385 (+2.18%)

APA APA Corp.
$33.29 /

+1.2 (+3.74%)

APA APA Corp.
$33.29 /

+1.2 (+3.74%)

ALTM Altus Midstream
$64.95 /

+1.385 (+2.18%)

APA APA Corp.
$33.29 /

+1.2 (+3.74%)

Conference/Events
JPMorgan utilities/midstream analyst holds analyst/industry conference call » 17:07
01/17/22
01/17
17:07
01/17/22
17:07

Utilities & Midstream…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Conference/Events
Guidewire participates in a conference call with JPMorgan » 17:04
01/17/22
01/17
17:04
01/17/22
17:04
GWRE

Guidewire

$103.74 /

-0.02 (-0.02%)

Software Analyst Ader…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GWRE Guidewire
$103.74 /

-0.02 (-0.02%)

GWRE Guidewire
$103.74 /

-0.02 (-0.02%)

12/03/21 BTIG
Guidewire price target raised to $146 from $138 at BTIG
12/03/21 Citi
Guidewire price target lowered to $132 from $138 at Citi
11/22/21 Barclays
Duck Creek Technologies upgraded to Overweight from Equal Weight at Barclays
10/04/21 BofA
Guidewire downgraded to Underperform from Neutral at BofA
GWRE Guidewire
$103.74 /

-0.02 (-0.02%)

GWRE Guidewire
$103.74 /

-0.02 (-0.02%)

GWRE Guidewire
$103.74 /

-0.02 (-0.02%)

Conference/Events
JPMorgan utilities/midstream analyst holds analyst/industry conference call » 16:56
01/17/22
01/17
16:56
01/17/22
16:56

Utilities & Midstream…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Conference/Events
JPMorgan business/info services analyst holds analyst/industry conference call » 16:52
01/17/22
01/17
16:52
01/17/22
16:52
DNB

Dun & Bradstreet

$19.68 /

+0.105 (+0.54%)

, MCO

Moody's

$353.50 /

-9.07 (-2.50%)

, TRI

Thomson Reuters

$109.64 /

-1.065 (-0.96%)

Business &…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
DNB Dun & Bradstreet
$19.68 /

+0.105 (+0.54%)

MCO Moody's
$353.50 /

-9.07 (-2.50%)

TRI Thomson Reuters
$109.64 /

-1.065 (-0.96%)

DNB Dun & Bradstreet
$19.68 /

+0.105 (+0.54%)

12/10/21 RBC Capital
Dun & Bradstreet price target lowered to $20 from $24 at RBC Capital
09/29/21 Citi
Dun & Bradstreet price target lowered to $21 from $28 at Citi
07/07/21 RBC Capital
Dun & Bradstreet assumed with an Outperform at RBC Capital
06/10/21 Raymond James
Dun & Bradstreet upgraded to Outperform from Market Perform at Raymond James
MCO Moody's
$353.50 /

-9.07 (-2.50%)

01/14/22 BMO Capital
Moody's price target raised to $430 from $428 at BMO Capital
10/29/21 Credit Suisse
Moody's price target raised to $475 from $425 at Credit Suisse
10/18/21 BMO Capital
Moody's price target raised to $423 from $415 at BMO Capital
09/07/21 Oppenheimer
Moody's price target raised to $418 from $406 at Oppenheimer
TRI Thomson Reuters
$109.64 /

-1.065 (-0.96%)

01/11/22 National Bank
Thomson Reuters upgraded to Outperform from Sector Perform at National Bank
11/03/21 TD Securities
Thomson Reuters price target raised to C$165 from C$160 at TD Securities
11/03/21 Canaccord
Thomson Reuters price target raised to $117 from $108 at Canaccord
11/03/21 Exane BNP Paribas
Thomson Reuters upgraded to Neutral from Underperform at Exane BNP Paribas
DNB Dun & Bradstreet
$19.68 /

+0.105 (+0.54%)

MCO Moody's
$353.50 /

-9.07 (-2.50%)

TRI Thomson Reuters
$109.64 /

-1.065 (-0.96%)

  • 28
    Jun
On The Fly
Box Office Battle: 'Scream' wins MLK weekend with $34M debut » 15:49
01/17/22
01/17
15:49
01/17/22
15:49
T

AT&T

$27.18 /

+0.37 (+1.38%)

, CMCSA

Comcast

$51.69 /

+0.33 (+0.64%)

, CMCSK

Comcast

$58.00 /

+ (+0.00%)

, SONY

Sony

$124.80 /

+0.08 (+0.06%)

, LGF.A

Lionsgate

$18.33 /

-0.01 (-0.05%)

, LGF.B

Lionsgate

$16.73 /

+0.02 (+0.12%)

, DIS

Disney

$151.94 /

-3.6 (-2.31%)

, VIACA

ViacomCBS

$41.18 /

+0.78 (+1.93%)

, VIAC

ViacomCBS

$36.83 /

+0.64 (+1.77%)

"Box Office Battle" is…

ShowHide Related Items >><<
VIACA ViacomCBS
$41.18 /

+0.78 (+1.93%)

VIAC ViacomCBS
$36.83 /

+0.64 (+1.77%)

T AT&T
$27.18 /

+0.37 (+1.38%)

SONY Sony
$124.80 /

+0.08 (+0.06%)

LGF.B Lionsgate
$16.73 /

+0.02 (+0.12%)

LGF.A Lionsgate
$18.33 /

-0.01 (-0.05%)

DIS Disney
$151.94 /

-3.6 (-2.31%)

CMCSK Comcast
$58.00 /

+ (+0.00%)

CMCSA Comcast
$51.69 /

+0.33 (+0.64%)

T AT&T
$27.18 /

+0.37 (+1.38%)

01/11/22 Citi
Citi adds Crown Castle, Switch to 'Positive Catalyst Watch List'
01/11/22 Citi
Citi adds AT&T to 'positive catalyst watch list,' keeps $29 target
01/07/22 Wells Fargo
Wells upgrades AT&T to neutral with downside risks 'more limited'
01/07/22 Wells Fargo
AT&T upgraded to Equal Weight from Underweight at Wells Fargo
CMCSA Comcast
$51.69 /

+0.33 (+0.64%)

01/11/22 Goldman Sachs
Comcast still top pick in cable at Goldman Sachs
01/10/22 Deutsche Bank
Comcast named a top pick for 2022, favorite cable stock at Deutsche Bank
12/15/21
Fly Intel: Top five analyst downgrades
12/15/21 Citi
Comcast downgraded to Neutral from Buy at Citi
CMCSK Comcast
$58.00 /

+ (+0.00%)

02/23/21 Credit Suisse
SeaWorld price target raised to $52 from $34 at Credit Suisse
SONY Sony
$124.80 /

+0.08 (+0.06%)

09/27/21 Cowen
Sony initiated with an Outperform at Cowen
09/10/21 Truist
Apple will likely appeal ruling in Epic case, says Truist
07/27/21 Morgan Stanley
Sony upgraded to Overweight at Morgan Stanley on animation business growth
07/27/21 Morgan Stanley
Sony upgraded to Overweight from Equal Weight at Morgan Stanley
LGF.A Lionsgate
$18.33 /

-0.01 (-0.05%)

01/04/22 Wells Fargo
Lionsgate upgraded to Overweight from Equal Weight at Wells Fargo
12/14/21 Macquarie
Lionsgate downgraded to Neutral at Macquarie as 'streaming wars go global'
12/14/21 Macquarie
Lionsgate downgraded to Neutral from Outperform at Macquarie
10/13/21
Fly Intel: Top five analyst initiations
LGF.B Lionsgate
$16.73 /

+0.02 (+0.12%)

01/04/22 Wells Fargo
Wells Fargo upgrades Lionsgate to Overweight, raises price target to $25
DIS Disney
$151.94 /

-3.6 (-2.31%)

01/14/22 Guggenheim
Disney downgraded to Neutral at Guggenheim on slower profit climb
01/14/22 Wedbush
Apple pursuing sports content would be 'right move at right time,' says Wedbush
01/14/22 JPMorgan
Disney remains top pick in media at JPMorgan
01/14/22 Guggenheim
Disney downgraded to Neutral from Buy at Guggenheim
VIACA ViacomCBS
$41.18 /

+0.78 (+1.93%)

12/14/21 Macquarie
ViacomCBS price target lowered to $32 from $40 at Macquarie
VIAC ViacomCBS
$36.83 /

+0.64 (+1.77%)

01/10/22 Deutsche Bank
Deutsche Bank upgrades ViacomCBS to Buy, calls top media pick
01/10/22 Deutsche Bank
ViacomCBS upgraded to Buy from Hold at Deutsche Bank
10/15/21 Deutsche Bank
ViacomCBS price target lowered to $44 from $45 at Deutsche Bank
VIACA ViacomCBS
$41.18 /

+0.78 (+1.93%)

T AT&T
$27.18 /

+0.37 (+1.38%)

SONY Sony
$124.80 /

+0.08 (+0.06%)

LGF.A Lionsgate
$18.33 /

-0.01 (-0.05%)

DIS Disney
$151.94 /

-3.6 (-2.31%)

CMCSA Comcast
$51.69 /

+0.33 (+0.64%)

  • 06
    Apr
  • 29
    Mar
  • 24
    Mar
VIACA ViacomCBS
$41.18 /

+0.78 (+1.93%)

T AT&T
$27.18 /

+0.37 (+1.38%)

SONY Sony
$124.80 /

+0.08 (+0.06%)

LGF.A Lionsgate
$18.33 /

-0.01 (-0.05%)

DIS Disney
$151.94 /

-3.6 (-2.31%)

CMCSK Comcast
$58.00 /

+ (+0.00%)

CMCSA Comcast
$51.69 /

+0.33 (+0.64%)

VIACA ViacomCBS
$41.18 /

+0.78 (+1.93%)

VIAC ViacomCBS
$36.83 /

+0.64 (+1.77%)

T AT&T
$27.18 /

+0.37 (+1.38%)

SONY Sony
$124.80 /

+0.08 (+0.06%)

DIS Disney
$151.94 /

-3.6 (-2.31%)

CMCSK Comcast
$58.00 /

+ (+0.00%)

CMCSA Comcast
$51.69 /

+0.33 (+0.64%)

VIAC ViacomCBS
$36.83 /

+0.64 (+1.77%)

T AT&T
$27.18 /

+0.37 (+1.38%)

DIS Disney
$151.94 /

-3.6 (-2.31%)

CMCSA Comcast
$51.69 /

+0.33 (+0.64%)

Periodicals
Major airline CEOs warn 5G could ground some planes, wreak havoc, Reuters says » 15:35
01/17/22
01/17
15:35
01/17/22
15:35
T

AT&T

$27.18 /

+0.37 (+1.38%)

, VZ

Verizon

$53.29 /

-0.24 (-0.45%)

, AAL

American Airlines

$18.50 /

-0.84 (-4.34%)

, DAL

Delta Air Lines

$40.31 /

-1.15 (-2.77%)

, UAL

United Airlines

$46.74 /

-1.39 (-2.89%)

, LUV

Southwest

$45.84 /

+0.045 (+0.10%)

The chief executives of…

The chief executives of major U.S. passenger and cargo carriers on Monday warned of an impending "catastrophic" aviation crisis on Wednesday when AT&T (T) and Verizon (VZ) are set to deploy new 5G service, Reuters' David Shepardson reports. The airlines warned the new C-Band 5G service could potentially make a significant number of widebody aircraft unusable and "could potentially strand tens of thousands of Americans overseas." "Unless our major hubs are cleared to fly, the vast majority of the traveling and shipping public will essentially be grounded," wrote the chief executives of American Airlines (AAL), Delta Air Lines (DAL), United Airlines (UAL), Southwest Airlines (LUV) and others. Reference Link

ShowHide Related Items >><<
VZ Verizon
$53.29 /

-0.24 (-0.45%)

UAL United Airlines
$46.74 /

-1.39 (-2.89%)

T AT&T
$27.18 /

+0.37 (+1.38%)

LUV Southwest
$45.84 /

+0.045 (+0.10%)

DAL Delta Air Lines
$40.31 /

-1.15 (-2.77%)

AAL American Airlines
$18.50 /

-0.84 (-4.34%)

T AT&T
$27.18 /

+0.37 (+1.38%)

01/11/22 Citi
Citi adds Crown Castle, Switch to 'Positive Catalyst Watch List'
01/11/22 Citi
Citi adds AT&T to 'positive catalyst watch list,' keeps $29 target
01/07/22 Wells Fargo
Wells upgrades AT&T to neutral with downside risks 'more limited'
01/07/22 Wells Fargo
AT&T upgraded to Equal Weight from Underweight at Wells Fargo
VZ Verizon
$53.29 /

-0.24 (-0.45%)

01/11/22 Goldman Sachs
Verizon downgraded to Buy from Conviction Buy at Goldman Sachs
12/23/21
Fly Intel: Top five analyst initiations
12/23/21 Daiwa
Verizon initiated with a Neutral at Daiwa
AAL American Airlines
$18.50 /

-0.84 (-4.34%)

01/11/22 Morgan Stanley
American Airlines upgraded to Equal Weight from Underweight at Morgan Stanley
01/07/22 BofA
BofA upgrades Delta to Buy, thinks poor sentiment could set up bounce
01/03/22 Citi
Citi says omicron 'modest' risk to airlines, names Frontier preferred pick
12/06/21 Evercore ISI
American Airlines upgraded to In Line at Evercore ISI following 15% pullback
DAL Delta Air Lines
$40.31 /

-1.15 (-2.77%)

01/14/22 Raymond James
Delta Air Lines price target lowered to $53 from $55 at Raymond James
01/14/22 Barclays
Delta Air Lines price target lowered to $45 from $50 at Barclays
01/13/22 Goldman Sachs
Delta Air Lines price target raised to $40 from $39 at Goldman Sachs
01/13/22 Susquehanna
Delta Air Lines upgraded to Positive with $50 price target at Susquehanna
UAL United Airlines
$46.74 /

-1.39 (-2.89%)

01/14/22 Barclays
United Airlines price target lowered to $52 from $58 at Barclays
01/13/22 Susquehanna
United Airlines upgraded to Positive with $60 price target at Susquehanna
01/13/22 Susquehanna
United Airlines upgraded to Positive from Neutral at Susquehanna
LUV Southwest
$45.84 /

+0.045 (+0.10%)

01/14/22 Barclays
Southwest price target lowered to $59 from $65 at Barclays
01/13/22 Susquehanna
Southwest downgraded to Neutral from Positive at Susquehanna
01/12/22 Wolfe Research
Southwest downgraded to Peer Perform from Outperform at Wolfe Research
01/12/22 Wolfe Research
Southwest downgraded to Peer Perform from Outperform at Wolfe Research
VZ Verizon
$53.29 /

-0.24 (-0.45%)

UAL United Airlines
$46.74 /

-1.39 (-2.89%)

T AT&T
$27.18 /

+0.37 (+1.38%)

LUV Southwest
$45.84 /

+0.045 (+0.10%)

DAL Delta Air Lines
$40.31 /

-1.15 (-2.77%)

AAL American Airlines
$18.50 /

-0.84 (-4.34%)

VZ Verizon
$53.29 /

-0.24 (-0.45%)

UAL United Airlines
$46.74 /

-1.39 (-2.89%)

T AT&T
$27.18 /

+0.37 (+1.38%)

DAL Delta Air Lines
$40.31 /

-1.15 (-2.77%)

AAL American Airlines
$18.50 /

-0.84 (-4.34%)

VZ Verizon
$53.29 /

-0.24 (-0.45%)

UAL United Airlines
$46.74 /

-1.39 (-2.89%)

T AT&T
$27.18 /

+0.37 (+1.38%)

LUV Southwest
$45.84 /

+0.045 (+0.10%)

DAL Delta Air Lines
$40.31 /

-1.15 (-2.77%)

AAL American Airlines
$18.50 /

-0.84 (-4.34%)

VZ Verizon
$53.29 /

-0.24 (-0.45%)

UAL United Airlines
$46.74 /

-1.39 (-2.89%)

T AT&T
$27.18 /

+0.37 (+1.38%)

LUV Southwest
$45.84 /

+0.045 (+0.10%)

DAL Delta Air Lines
$40.31 /

-1.15 (-2.77%)

AAL American Airlines
$18.50 /

-0.84 (-4.34%)

Periodicals
Atlantia agrees to acquire Siemens' traffic unit for $1.1B, Bloomberg reports » 15:28
01/17/22
01/17
15:28
01/17/22
15:28
ATASY

Atlantia

$9.84 /

+0.035 (+0.36%)

, SIEGY

Siemens

$83.76 /

-2.315 (-2.69%)

Atlantia (ATASY) agreed…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SIEGY Siemens
$83.76 /

-2.315 (-2.69%)

ATASY Atlantia
$9.84 /

+0.035 (+0.36%)

10/26/21 UBS
Atlantia price target raised to EUR 18.80 from EUR 18.20 at UBS
08/11/21 Societe Generale
Atlantia upgraded to Buy from Hold at Societe Generale
05/14/21 Oddo BHF
Atlantia upgraded to Neutral from Underperform at Oddo BHF
SIEGY Siemens
$83.76 /

-2.315 (-2.69%)

01/14/22 Barclays
Siemens price target raised to EUR 141 from EUR 130 at Barclays
01/12/22 Deutsche Bank
Siemens price target raised to EUR 185 from EUR 180 at Deutsche Bank
12/07/21 Bernstein
Siemens initiated with an Underperform at Bernstein
11/26/21 Deutsche Bank
Siemens price target raised to EUR 180 from EUR 178 at Deutsche Bank
SIEGY Siemens
$83.76 /

-2.315 (-2.69%)

SIEGY Siemens
$83.76 /

-2.315 (-2.69%)

Periodicals
Study says 4th Pfizer doze insufficient to ward off Omicron, Bloomberg reports » 15:24
01/17/22
01/17
15:24
01/17/22
15:24
PFE

Pfizer

$54.94 /

-0.59 (-1.06%)

, BNTX

BioNTech

$196.03 /

-6.99 (-3.44%)

A fourth dose of the…

A fourth dose of the Pfizer (PFE)-BioNTech (BNTX) vaccine was insufficient to prevent infection with the omicron variant of COVID-19, Bloomberg's Daniel Avis reports, citing preliminary data from a trial in Israel released Monday. Two weeks after the start of the trial of 154 medical personnel at the Sheba Medical Center in Tel Aviv, researchers found the vaccine successfully raised antibody levels. But that only offered a partial defense against omicron, according to Gili Regev-Yochay, the trial's lead researcher. Vaccines which were more effective against previous variants offer less protection with omicron, she said. Still, those infected in the trial had only slight symptoms or none at all. Reference Link

ShowHide Related Items >><<
PFE Pfizer
$54.94 /

-0.59 (-1.06%)

BNTX BioNTech
$196.03 /

-6.99 (-3.44%)

PFE Pfizer
$54.94 /

-0.59 (-1.06%)

01/14/22 BMO Capital
Pfizer price target raised to $76 from $60 at BMO Capital
01/11/22 BofA
Pfizer added to US 1 List; Goldman Sachs removed at BofA
01/10/22 Wedbush
Beam Therapeutics price target raised to $159 from $148 at Wedbush
01/05/22 BofA
Pfizer upgraded to Buy from Neutral at BofA
BNTX BioNTech
$196.03 /

-6.99 (-3.44%)

12/22/21 Kempen
BioNTech upgraded to Buy from Neutral at Kempen
12/21/21 H.C. Wainwright
BioNTech price target raised to $366 from $360 at H.C. Wainwright
12/16/21 Morgan Stanley
BioNTech initiated with an Equal Weight at Morgan Stanley
12/06/21 BofA
BioNTech price target raised to $349 from $341 at BofA
PFE Pfizer
$54.94 /

-0.59 (-1.06%)

BNTX BioNTech
$196.03 /

-6.99 (-3.44%)

PFE Pfizer
$54.94 /

-0.59 (-1.06%)

BNTX BioNTech
$196.03 /

-6.99 (-3.44%)

PFE Pfizer
$54.94 /

-0.59 (-1.06%)

BNTX BioNTech
$196.03 /

-6.99 (-3.44%)

PFE Pfizer
$54.94 /

-0.59 (-1.06%)

BNTX BioNTech
$196.03 /

-6.99 (-3.44%)

On The Fly
Fly Intel: What to watch in next round of big bank earnings reports » 15:19
01/17/22
01/17
15:19
01/17/22
15:19
GS

Goldman Sachs

$380.90 /

-10.04 (-2.57%)

, BAC

Bank of America

$47.90 /

-0.87 (-1.78%)

, MS

Morgan Stanley

$98.88 /

-3.68 (-3.59%)

Goldman Sachs (GS) is…

ShowHide Related Items >><<
MS Morgan Stanley
$98.88 /

-3.68 (-3.59%)

GS Goldman Sachs
$380.90 /

-10.04 (-2.57%)

BAC Bank of America
$47.90 /

-0.87 (-1.78%)

GS Goldman Sachs
$380.90 /

-10.04 (-2.57%)

01/11/22 BofA
Pfizer added to US 1 List; Goldman Sachs removed at BofA
01/06/22 BofA
Goldman Sachs downgraded to Neutral from Buy at BofA
01/03/22 Barclays
Goldman Sachs price target raised to $556 from $483 at Barclays
12/06/21 Morgan Stanley
Goldman Sachs upgraded to Equal Weight at Morgan Stanley
BAC Bank of America
$47.90 /

-0.87 (-1.78%)

01/12/22 Citi
Citi opens '30-Day Positive Catalyst Watch' on Bank of America
01/11/22 Piper Sandler
Bank of America the large cap bank stock to own for 2022, says Piper Sandler
01/06/22 JPMorgan
Bank of America price target raised to $52.50 from $50 at JPMorgan
01/05/22 Societe Generale
Bank of America downgraded to Hold at Societe Generale on expensive valuation
MS Morgan Stanley
$98.88 /

-3.68 (-3.59%)

01/03/22 Barclays
Morgan Stanley price target raised to $123 from $110 at Barclays
12/03/21
Fly Intel: Top five analyst upgrades
12/03/21 Citi
Morgan Stanley upgraded to Buy from Neutral at Citi
10/18/21 Citi
Morgan Stanley price target raised to $105 from $100 at Citi
MS Morgan Stanley
$98.88 /

-3.68 (-3.59%)

GS Goldman Sachs
$380.90 /

-10.04 (-2.57%)

BAC Bank of America
$47.90 /

-0.87 (-1.78%)

MS Morgan Stanley
$98.88 /

-3.68 (-3.59%)

GS Goldman Sachs
$380.90 /

-10.04 (-2.57%)

BAC Bank of America
$47.90 /

-0.87 (-1.78%)

MS Morgan Stanley
$98.88 /

-3.68 (-3.59%)

GS Goldman Sachs
$380.90 /

-10.04 (-2.57%)

BAC Bank of America
$47.90 /

-0.87 (-1.78%)

MS Morgan Stanley
$98.88 /

-3.68 (-3.59%)

GS Goldman Sachs
$380.90 /

-10.04 (-2.57%)

BAC Bank of America
$47.90 /

-0.87 (-1.78%)

Conference/Events
Plug Power to host business news update conference call » 15:08
01/17/22
01/17
15:08
01/17/22
15:08
PLUG

Plug Power

$23.43 /

-0.48 (-2.01%)

Management holds a…

Management holds a business news update conference call on January 19 at 10 am.Webcast Link

ShowHide Related Items >><<
PLUG Plug Power
$23.43 /

-0.48 (-2.01%)

PLUG Plug Power
$23.43 /

-0.48 (-2.01%)

01/13/22 Morgan Stanley
Clean Tech industry view upgraded to Attractive at Morgan Stanley
01/11/22 Citi
Plug Power price target lowered to $37 from $56 at Citi
01/05/22 KeyBanc
Plug Power initiated with an Overweight at KeyBanc
11/20/21 Citi
Citi initiates pair trade of Overweight Plug Power, Underweight Ballard Power
PLUG Plug Power
$23.43 /

-0.48 (-2.01%)

  • 27
    Jan
PLUG Plug Power
$23.43 /

-0.48 (-2.01%)

PLUG Plug Power
$23.43 /

-0.48 (-2.01%)

Hot Stocks
Spirit Airlines appoints Linde Grindle as Chief Human Resources Officer » 14:22
01/17/22
01/17
14:22
01/17/22
14:22
SAVE

Spirit Airlines

$23.30 /

-0.48 (-2.02%)

Spirit Airlines announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SAVE Spirit Airlines
$23.30 /

-0.48 (-2.02%)

SAVE Spirit Airlines
$23.30 /

-0.48 (-2.02%)

01/14/22 Barclays
Spirit Airlines price target lowered to $38 from $46 at Barclays
01/13/22 Susquehanna
Spirit Airlines downgraded on cost pressures at Susquehanna
01/13/22 Susquehanna
Spirit Airlines downgraded to Neutral from Positive at Susquehanna
01/03/22 MKM Partners
Spirit Airlines downgraded to Neutral from Buy at MKM Partners
SAVE Spirit Airlines
$23.30 /

-0.48 (-2.02%)

SAVE Spirit Airlines
$23.30 /

-0.48 (-2.02%)

SAVE Spirit Airlines
$23.30 /

-0.48 (-2.02%)

SAVE Spirit Airlines
$23.30 /

-0.48 (-2.02%)

Hot Stocks
IHS Markit declares quarterly cash dividend in Q1 of 20c per share » 14:15
01/17/22
01/17
14:15
01/17/22
14:15
INFO

IHS Markit

$121.74 /

-1.05 (-0.86%)

IHS Markit announced that…

IHS Markit announced that its Board of Directors has declared a quarterly cash dividend in the first quarter of 2022, in the amount of 20c per share. The cash dividend is payable on February 11, 2022 to common shareholders of record at the close of business on January 28, 2022. The Markit Group Holdings Limited Employee Benefit Trust, has, subject to certain limited exceptions, waived its right to receive dividends with respect to common shares it holds and, as a result, it will not participate in the dividend payable on February 11, 2022.

ShowHide Related Items >><<
INFO IHS Markit
$121.74 /

-1.05 (-0.86%)

INFO IHS Markit
$121.74 /

-1.05 (-0.86%)

12/28/21 Baird
S&P Global divestitures done satisfy merger regulatory conditions, says Baird
09/16/21 Oppenheimer
S&P Global price target raised to $550 from $476 at Oppenheimer
07/15/21 Deutsche Bank
IHS Markit price target raised to $127 from $123 at Deutsche Bank
07/15/21 Deutsche Bank
S&P Global price target raised to $450 from $435 at Deutsche Bank
INFO IHS Markit
$121.74 /

-1.05 (-0.86%)

  • 29
    Jun
  • 11
    May
INFO IHS Markit
$121.74 /

-1.05 (-0.86%)

INFO IHS Markit
$121.74 /

-1.05 (-0.86%)

Hot Stocks
Enhertu granted priority review in HER2-positive metastatic breast cancer » 14:11
01/17/22
01/17
14:11
01/17/22
14:11
AZN

AstraZeneca

$58.86 /

+0.745 (+1.28%)

AstraZeneca and Daiichi…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AZN AstraZeneca
$58.86 /

+0.745 (+1.28%)

AZN AstraZeneca
$58.86 /

+0.745 (+1.28%)

12/30/21 SVB Leerink
SVB Leerink confident Adbry poses minimal competitive risk to Dupixent
12/16/21 Morgan Stanley
AstraZeneca price target raised to 10,200 GBp from 10,000 GBp at Morgan Stanley
12/16/21 Stifel
Adagio story 'even more complicated' after preprints on ADG20, says Stifel
12/12/21 Piper Sandler
Schrodinger MALT1 preclinical data supports IND filing in 1H22, says Piper
AZN AstraZeneca
$58.86 /

+0.745 (+1.28%)

AZN AstraZeneca
$58.86 /

+0.745 (+1.28%)

AZN AstraZeneca
$58.86 /

+0.745 (+1.28%)

AZN AstraZeneca
$58.86 /

+0.745 (+1.28%)

Hot Stocks
Evelo Biosciences presents data for EDP1815 » 14:08
01/17/22
01/17
14:08
01/17/22
14:08
EVLO

Evelo Biosciences

$5.49 /

-0.085 (-1.52%)

Evelo Biosciences…

Evelo Biosciences announced data for EDP1815, the company's lead product in inflammation, detailing its mechanism of action and supporting further clinical development in patients with psoriasis and atopic dermatitis. The data were presented in two posters on Saturday, January 15, 2022, at the 2022 Winter Clinical Dermatology Congress in Koloa, Hawaii. Preclinical data from the studies presented at the Winter Clinical Dermatology Congress confirm that EDP1815 modulates systemic inflammation through its initial interaction with innate immune receptors, including TLR2, leading to downstream changes in circulating immune-cell phenotypes. In addition, the data demonstrate that preclinical effects in Th17 models translate into signs of clinical benefit in psoriasis, and that preclinical effects in Th2 models translate into signs of clinical benefit in atopic dermatitis, supporting further clinical development of EDP1815 in these indications. A Phase 2 study of EDP1815 in patients with mild to moderate psoriasis is ongoing, and a Phase 2 study of EDP1815 in patients with mild, moderate, and severe atopic dermatitis is expected to initiate dosing in the first quarter of 2022.

ShowHide Related Items >><<
EVLO Evelo Biosciences
$5.49 /

-0.085 (-1.52%)

EVLO Evelo Biosciences
$5.49 /

-0.085 (-1.52%)

11/01/21 Chardan
Evelo Biosciences upgraded to Buy on valuation at Chardan
11/01/21 Chardan
Evelo Biosciences upgraded to Buy from Neutral at Chardan
10/19/21 Morgan Stanley
Evelo Biosciences assumed with an Equal Weight at Morgan Stanley
09/28/21 Jefferies
Evelo Biosciences price target lowered to $14 from $18 at Jefferies
EVLO Evelo Biosciences
$5.49 /

-0.085 (-1.52%)

  • 29
    Jan
EVLO Evelo Biosciences
$5.49 /

-0.085 (-1.52%)

Hot Stocks
Check Point report shows DHL most imitated brand in phishing attempts in Q4 » 14:03
01/17/22
01/17
14:03
01/17/22
14:03
CHKP

Check Point

$126.15 /

+6.77 (+5.67%)

, DPSGY

Deutsche Post

$62.26 /

-0.14 (-0.22%)

, MSFT

Microsoft

$310.01 /

+4.93 (+1.62%)

, FDX

FedEx

$256.18 /

-1.38 (-0.54%)

, FB

Facebook; also tag MVRS

$332.00 /

+5.5 (+1.68%)

, MVRS

Meta

/

+

Check Point Research, the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MSFT Microsoft
$310.01 /

+4.93 (+1.62%)

FDX FedEx
$256.18 /

-1.38 (-0.54%)

FB Facebook; also tag MVRS
$332.00 /

+5.5 (+1.68%)

CHKP Check Point
$126.15 /

+6.77 (+5.67%)

CHKP Check Point
$126.15 /

+6.77 (+5.67%)

01/14/22 Raymond James
Check Point upgraded to Outperform from Market Perform at Raymond James
01/14/22 Raymond James
Check Point upgraded to Outperform from Market Perform at Raymond James
12/15/21 Mizuho
Check Point price target lowered to $125 from $135 at Mizuho
11/16/21 Credit Suisse
Check Point initiated with an Underperform at Credit Suisse
DPSGY Deutsche Post
$62.26 /

-0.14 (-0.22%)

01/12/22 JPMorgan
Deutsche Post price target raised to EUR 75.05 from EUR 72 at JPMorgan
11/05/21 JPMorgan
Deutsche Post price target lowered to EUR 72 from EUR 73.44 at JPMorgan
10/07/21 JPMorgan
Deutsche Post price target lowered to EUR from EUR 76.10 at JPMorgan
09/29/21 Goldman Sachs
Deutsche Post downgraded to Buy from Conviction Buy at Goldman Sachs
MSFT Microsoft
$310.01 /

+4.93 (+1.62%)

01/13/22 Wedbush
Cloud spending looks robust in 2022 for Microsoft, says Wedbush
01/12/22 BMO Capital
Microsoft price target raised to $360 from $355 at BMO Capital
01/11/22 Morgan Stanley
Amazon price target raised to $4,200 from $4,000 at Morgan Stanley
01/11/22 KeyBanc
KeyBanc upgrades AMD to Overweight with $155 price target
FDX FedEx
$256.18 /

-1.38 (-0.54%)

12/29/21 Argus
FedEx price target raised to $285 from $270 at Argus
12/20/21 Credit Suisse
FedEx price target raised to $336 from $330 at Credit Suisse
12/17/21 JPMorgan
FedEx price target raised to $312 from $305 at JPMorgan
12/17/21 Stephens
FedEx price target raised to $345 from $330 at Stephens
FB Facebook; also tag MVRS
$332.00 /

+5.5 (+1.68%)

01/12/22 Craig-Hallum
Craig-Hallum bullish on BuzzFeed, initiates with a Buy
01/11/22 JPMorgan
Amazon 'strong favorite' to be best performing FANG stock, JPMorgan says
MVRS Meta
/

+

12/29/21 Baird
Baird announces three new top internet stock picks for 2022
MSFT Microsoft
$310.01 /

+4.93 (+1.62%)

FDX FedEx
$256.18 /

-1.38 (-0.54%)

FB Facebook; also tag MVRS
$332.00 /

+5.5 (+1.68%)

CHKP Check Point
$126.15 /

+6.77 (+5.67%)

MVRS Meta
/

+

MSFT Microsoft
$310.01 /

+4.93 (+1.62%)

FDX FedEx
$256.18 /

-1.38 (-0.54%)

FB Facebook; also tag MVRS
$332.00 /

+5.5 (+1.68%)

DPSGY Deutsche Post
$62.26 /

-0.14 (-0.22%)

MSFT Microsoft
$310.01 /

+4.93 (+1.62%)

FDX FedEx
$256.18 /

-1.38 (-0.54%)

FB Facebook; also tag MVRS
$332.00 /

+5.5 (+1.68%)

CHKP Check Point
$126.15 /

+6.77 (+5.67%)

MSFT Microsoft
$310.01 /

+4.93 (+1.62%)

FDX FedEx
$256.18 /

-1.38 (-0.54%)

FB Facebook; also tag MVRS
$332.00 /

+5.5 (+1.68%)

Hot Stocks
Unilever says GSK Consumer Healthcare would be 'strong strategic fit' » 11:21
01/17/22
01/17
11:21
01/17/22
11:21
UN

Unilever

$60.50 /

+ (+0.00%)

, UL

Unilever

$54.30 /

+0.645 (+1.20%)

, GSK

GlaxoSmithKline

$45.48 /

+0.44 (+0.98%)

Unilever (UN, UL)…

Unilever (UN, UL) announced that it is "committed to accelerating the company's growth and repositioning the portfolio into higher growth categories." It added, "As a result of the reporting of Unilever's interest in GSK (GSK) Consumer Healthcare, we are today bringing forward a planned update, setting out the strategic direction that the company is pursuing." Unilever announced that its board has undertaken an "extensive process to review strategic pathways to reposition Unilever's portfolio into higher growth categories." This concluded that Unilever's future strategic direction "lies in materially expanding its presence in Health, Beauty, and Hygiene. These categories offer higher rates of sustainable market growth, with significant opportunities to drive growth through investment and innovation, and by leveraging Unilever's strong presence in emerging markets," the company said in a statement. The board also concluded "that major acquisitions should be accompanied by the accelerated divestment of intrinsically lower growth brands and businesses." It added, "Unilever is committed to strict financial discipline to ensure that acquisitions create value for shareholders. The company benefits from a strong balance sheet and cash generation, and remains committed to maintaining an A-band credit rating. Following any acquisition, the company would target a return to current levels of gearing over the short to medium term. Consumer Health is a highly complementary category for Unilever, with good potential for synergies and a number of routes to build scale. GSK Consumer Healthcare would be a strong strategic fit." Reference Link

ShowHide Related Items >><<
UN Unilever
$60.50 /

+ (+0.00%)

GSK GlaxoSmithKline
$45.48 /

+0.44 (+0.98%)

UN Unilever
$60.50 /

+ (+0.00%)

08:15 Today Bernstein
Unilever downgraded to Underperform from Market Perform at Bernstein
08:10 Today Barclays
Unilever downgraded to Equal Weight from Overweight at Barclays
01/10/22 Citi
Unilever resumed with a Buy at Citi
11/01/21 Bernstein
Unilever upgraded to Market Perform from Underperform at Bernstein
UL Unilever
$54.30 /

+0.645 (+1.20%)

GSK GlaxoSmithKline
$45.48 /

+0.44 (+0.98%)

01/04/22 JPMorgan
GlaxoSmithKline price target raised to 1,710 GBp from 1,580 GBp at JPMorgan
01/04/22 JPMorgan
JPMorgan places 'positive Catalyst watch' on GSK, ups target
GSK GlaxoSmithKline
$45.48 /

+0.44 (+0.98%)

UN Unilever
$60.50 /

+ (+0.00%)

UL Unilever
$54.30 /

+0.645 (+1.20%)

GSK GlaxoSmithKline
$45.48 /

+0.44 (+0.98%)

UN Unilever
$60.50 /

+ (+0.00%)

UL Unilever
$54.30 /

+0.645 (+1.20%)

GSK GlaxoSmithKline
$45.48 /

+0.44 (+0.98%)

GSK GlaxoSmithKline
$45.48 /

+0.44 (+0.98%)

Periodicals
Activision fired or pushed out dozens over workplace misconduct, WSJ says » 11:15
01/17/22
01/17
11:15
01/17/22
11:15
ATVI

Activision Blizzard

$65.36 /

+1.18 (+1.84%)

Activision Blizzard has…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ATVI Activision Blizzard
$65.36 /

+1.18 (+1.84%)

ATVI Activision Blizzard
$65.36 /

+1.18 (+1.84%)

01/13/22 Edward Jones
Activision Blizzard downgraded to Hold from Buy at Edward Jones
12/20/21 Stifel
Activision Blizzard target lowered to $77, removed from 'Select List' at Stifel
11/22/21
Fly Intel: Top five analyst downgrades
11/22/21 MKM Partners
Activision Blizzard downgraded to Sell from Neutral at MKM Partners
ATVI Activision Blizzard
$65.36 /

+1.18 (+1.84%)

ATVI Activision Blizzard
$65.36 /

+1.18 (+1.84%)

ATVI Activision Blizzard
$65.36 /

+1.18 (+1.84%)

ATVI Activision Blizzard
$65.36 /

+1.18 (+1.84%)

Hot Stocks
Credit Suisse Chairman Horta-Osorio resigns after board investigation » 11:11
01/17/22
01/17
11:11
01/17/22
11:11
CS

Credit Suisse

$10.55 /

+0.04 (+0.38%)

Credit Suisse announced…

Credit Suisse announced that its board has appointed Axel Lehmann as the bank's new Chairman effective immediately. He succeeds Antonio Horta-Osorio, who resigned following an investigation commissioned by the board. Severin Schwan, Vice-Chairman and Lead Independent Director of the Board of Credit Suisse, said: "We respect Antonio's decision and owe him considerable thanks for his leadership in defining the new strategy, which we will continue to implement over the coming months and years. Axel Lehmann as the new Chairman, with his extensive international and Swiss industry experience, is ideally suited to drive forward the strategic and cultural transformation of the bank. We wish Axel every success in his new role and Antonio all the best for the future." Following his appointment by the board, Axel Lehmann has taken office as Chairman. The board will also propose him for election as Chairman at the upcoming annual general meeting on April 29. Reference Link

ShowHide Related Items >><<
CS Credit Suisse
$10.55 /

+0.04 (+0.38%)

CS Credit Suisse
$10.55 /

+0.04 (+0.38%)

01/07/22 Exane BNP Paribas
Credit Suisse downgraded to Neutral from Outperform at Exane BNP Paribas
01/06/22 JPMorgan
Credit Suisse price target raised to CHF 10.60 from CHF 10.40 at JPMorgan
01/06/22 Keefe Bruyette
Credit Suisse downgraded to Underperform from Market Perform at Keefe Bruyette
12/06/21 UBS
Credit Suisse downgraded to Neutral from Buy at UBS
CS Credit Suisse
$10.55 /

+0.04 (+0.38%)

CS Credit Suisse
$10.55 /

+0.04 (+0.38%)

CS Credit Suisse
$10.55 /

+0.04 (+0.38%)

CS Credit Suisse
$10.55 /

+0.04 (+0.38%)

General news
European Fixed Income Summary: » 09:35
01/17/22
01/17
09:35
01/17/22
09:35
$ECON

Economic Data

/

+

European Fixed Income…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

Hot Stocks
Amazon reverses upcoming ban on Visa cards in U.K. » 09:28
01/17/22
01/17
09:28
01/17/22
09:28
V

Visa

$214.71 /

-0.32 (-0.15%)

, AMZN

Amazon.com

$3,241.45 /

+19.2 (+0.60%)

Amazon.com (AMZN) has…

Amazon.com (AMZN) has emailed its customers in the U.K. to say that a planned ban on Visa (V) credit cards will no longer take place, according to various news outlets. "We are working closely with Visa on a potential solution that will enable customers to continue using their Visa credit cards on Amazon.co.uk," Amazon said in the email, according to Bloomberg. The previously announced ban, which Amazon said was due to the rising costs of accepting credit card payments, was due to take place on January 19. "Amazon customers can continue to use Visa cards on Amazon.co.uk after January 19 while we work closely together to reach an agreement," a Visa spokesman told Bloomberg.

ShowHide Related Items >><<
V Visa
$214.71 /

-0.32 (-0.15%)

AMZN Amazon.com
$3,241.45 /

+19.2 (+0.60%)

V Visa
$214.71 /

-0.32 (-0.15%)

01/10/22 Exane BNP Paribas
Visa downgraded on lack of 2022 catalysts at Exane BNP Paribas
01/10/22 Exane BNP Paribas
Visa downgraded to Neutral from Outperform at Exane BNP Paribas
01/07/22 Mizuho
Mizuho downgrades Visa on shortened cash-to-card conversion runway
01/07/22 Mizuho
Visa downgraded to Neutral from Buy at Mizuho
AMZN Amazon.com
$3,241.45 /

+19.2 (+0.60%)

01/14/22 Wedbush
Apple pursuing sports content would be 'right move at right time,' says Wedbush
01/13/22 Wedbush
Cloud spending looks robust in 2022 for Microsoft, says Wedbush
01/11/22 JPMorgan
Amazon 'strong favorite' to be best performing FANG stock, JPMorgan says
01/11/22 Morgan Stanley
Amazon price target raised to $4,200 from $4,000 at Morgan Stanley
V Visa
$214.71 /

-0.32 (-0.15%)

AMZN Amazon.com
$3,241.45 /

+19.2 (+0.60%)

V Visa
$214.71 /

-0.32 (-0.15%)

AMZN Amazon.com
$3,241.45 /

+19.2 (+0.60%)

V Visa
$214.71 /

-0.32 (-0.15%)

AMZN Amazon.com
$3,241.45 /

+19.2 (+0.60%)

V Visa
$214.71 /

-0.32 (-0.15%)

AMZN Amazon.com
$3,241.45 /

+19.2 (+0.60%)

Recommendations
Wells Fargo price target raised to $67 from $57 at Keefe Bruyette » 08:52
01/17/22
01/17
08:52
01/17/22
08:52
WFC

Wells Fargo

$58.08 /

+1.955 (+3.48%)

Keefe Bruyette analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
WFC Wells Fargo
$58.08 /

+1.955 (+3.48%)

WFC Wells Fargo
$58.08 /

+1.955 (+3.48%)

01/12/22 Piper Sandler
Wells Fargo upgraded to Overweight with $64 target at Piper Sandler
01/12/22 Piper Sandler
Wells Fargo upgraded to Overweight from Neutral at Piper Sandler
01/06/22 JPMorgan
Wells Fargo price target raised to $57 from $53.50 at JPMorgan
01/03/22 Barclays
Wells Fargo upgraded to Overweight from Equal Weight at Barclays
WFC Wells Fargo
$58.08 /

+1.955 (+3.48%)

WFC Wells Fargo
$58.08 /

+1.955 (+3.48%)

WFC Wells Fargo
$58.08 /

+1.955 (+3.48%)

WFC Wells Fargo
$58.08 /

+1.955 (+3.48%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.